| The gut-liver axis in immune remodeling: new insight into liver diseases X Yang, D Lu, J Zhuo, Z Lin, M Yang, X Xu International journal of biological sciences 16 (13), 2357, 2020 | 70 | 2020 |
| Single‐cell profiling reveals distinct immune phenotypes that contribute to ischaemia‐reperfusion injury after steatotic liver transplantation X Yang, D Lu, R Wang, Z Lian, Z Lin, J Zhuo, H Chen, M Yang, W Tan, ... Cell Proliferation 54 (10), e13116, 2021 | 33 | 2021 |
| Impact of extent of resection on survival in high-risk neuroblastoma: a systematic review and meta-analysis X Yang, J Chen, N Wang, Z Liu, F Li, J Zhou, B Tao Journal of pediatric surgery 54 (7), 1487-1494, 2019 | 26 | 2019 |
| One shoot, two birds: alleviating inflammation caused by ischemia/reperfusion injury to reduce the recurrence of hepatocellular carcinoma H Chen, D Lu, X Yang, Z Hu, C He, H Li, Z Lin, M Yang, X Xu Frontiers in Immunology 13, 879552, 2022 | 14 | 2022 |
| The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib J Zhuo, D Lu, Z Lin, X Yang, M Yang, J Wang, Y Tao, X Wen, H Li, Z Lian, ... Cell death & disease 12 (12), 1084, 2021 | 14 | 2021 |
| Clinical use of dendritic cell-derived exosomes for hepatocellular carcinoma immunotherapy: How far we are? X Yang, J Chen, N Wang, Z Liu, Y Li Journal of Hepatology 69 (4), 984-986, 2018 | 10 | 2018 |
| TNFR2 is a potent prognostic biomarker for post-transplant lung metastasis in patients with hepatocellular carcinoma H Li, Z Lin, J Zhuo, M Yang, W Shen, Z Hu, Y Ding, H Chen, C He, X Yang, ... Chinese Journal of Cancer Research 35 (1), 66, 2023 | 8 | 2023 |
| Multi-omics profiling reveals Chitinase-3-like protein 1 as a key mediator in the crosstalk between sarcopenia and liver cancer D Lu, Z Lin, R Wang, Z Chen, J Zhuo, L Xu, L Pan, H Li, X Yang, C He, ... Redox Biology 58, 102538, 2022 | 7 | 2022 |
| Metabolomic biomarkers for the diagnosis and post-transplant outcomes of AFP negative hepatocellular carcinoma Z Lin, H Li, C He, M Yang, H Chen, X Yang, J Zhuo, W Shen, Z Hu, L Pan, ... Frontiers in Oncology 13, 1072775, 2023 | 5 | 2023 |
| Liver organoids, novel and promising modalities for exploring and repairing liver injury C He, D Lu, Z Lin, H Chen, H Li, X Yang, M Yang, K Wang, X Wei, ... Stem Cell Reviews and Reports 19 (2), 345-357, 2023 | 5 | 2023 |
| Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein-negative hepatocellular carcinoma M Yang, W Tan, X Yang, J Zhuo, Z Lin, B Cen, Z Lian, H Li, D Lu, X Wei, ... Cancer Biomarkers 29 (2), 197-206, 2020 | 5 | 2020 |
| Double-negative T cells: a promising avenue of adoptive cell therapy in transplant oncology Z Hu, M Yang, H Chen, C He, Z Lin, X Yang, H Li, W Shen, D Lu, X Xu Journal of Zhejiang University-SCIENCE B 24 (5), 387-396, 2023 | 3 | 2023 |
| Dynamic immune cell profiling identified natural killer cell shift as the key event in early allograft dysfunction after liver transplantation D Lu, X Yang, L Pan, Z Lian, W Tan, J Zhuo, M Yang, Z Lin, Q Wei, J Chen, ... Cell Proliferation 57 (4), e13568, 2024 | 1 | 2024 |
| Fibroblast growth factor 21 (FGF21) attenuates tacrolimus-induced hepatic lipid accumulation through transcription factor EB (TFEB)-regulated lipophagy Z Zhang, L Xu, X Qiu, X Yang, Z Lian, X Wei, D Lu, X Xu Journal of Zhejiang University-SCIENCE B 24 (6), 485-495, 2023 | 1 | 2023 |
| FGF21-mediated autophagy: Remodeling the homeostasis in response to stress in liver diseases W Shen, M Yang, H Chen, C He, H Li, X Yang, J Zhuo, Z Lin, Z Hu, D Lu, ... Genes & Diseases, 2023 | | 2023 |
| Finding the Right Balance in Pregnancy After Liver Transplantation: The Graft Function Should Also Be Taken Into Account Y Wang, X Yang, H Chen, X Xu Official journal of the American College of Gastroenterology| ACG 117 (6 …, 2022 | | 2022 |
| An Inflammatory Liquid Fingerprint Predicting Tumor Recurrence after Liver Transplantation for Hepatocellular Carcinoma M Yang, Z Lin, L Zhuang, L Pan, R Wang, H Chen, Z Hu, W Shen, J Zhuo, ... | | |
